Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection

INTRODUCTION: Achieving functional cure of chronic HBV infection (Hepatitis B surface antigen [HBsAg] clearance, eventually followed by acquisition of anti-hepatitis B surface antigen [Anti-HBs]) in individuals with HIV and HBV infections is a rare event. In this setting, factors related to HBV cure...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Gantner, Pierre, Cotte, Laurent, Allavena, Clotilde, Bani-Sadr, Firouzé, Huleux, Thomas, Duvivier, Claudine, Valantin, Marc-Antoine, Jacomet, Christine, Joly, Véronique, Chéret, Antoine, Pugliese, Pascal, Delobel, Pierre, Cabié, André, Rey, David
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2019
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6472771/
https://ncbi.nlm.nih.gov/pubmed/30998789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0215464
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki